ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,625Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 179

$1.19M Total Retail Price of All Prescriptions

Rank: 2 out of 179

577 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 577 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

15% of this provider’s 577 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 10,911 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $125 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 822 478 1 1
METOPROLOL TARTRATE 636 433 2 24
FUROSEMIDE 633 455 3 17
LANTUS 627 339 4 7
INSULIN SYRINGE 508 250 5 8
METFORMIN HCL 469 263 6 2
GLIMEPIRIDE 435 369 7 10
SIMVASTATIN 394 285 8 6
AMLODIPINE BESYLATE 392 269 9 13
ISOSORBIDE MONONITRATE ER 338 241 10 63
TRAMADOL HCL 302 228 11 39
HYDRALAZINE HCL 295 235 12 69
NOVOLOG 289 145 13 18
ATORVASTATIN CALCIUM 285 199 14 15
WARFARIN SODIUM 280 241 15 29
HYDROCODONE-ACETAMINOPHEN 274 188 S3 16 28
HUMALOG 252 151 17 9
METOPROLOL SUCCINATE 246 155 18 22
LISINOPRIL 239 142 19 12
PEN NEEDLE 226 124 20 3
LANTUS SOLOSTAR 224 155 21 4
PANTOPRAZOLE SODIUM 206 162 22 54
ALLOPURINOL 198 139 23 40
CARVEDILOL 186 147 24 36
CLOPIDOGREL 185 124 25 70
CRESTOR 185 123 25 25
GABAPENTIN 175 107 27 41
POTASSIUM CHLORIDE 168 116 28 46
OMEPRAZOLE 150 81 29 23
ENALAPRIL MALEATE 143 66 30 42
SYNTHROID 138 106 31 5
PLAVIX 123 91 32 100
NEXIUM 122 79 33 59
BENICAR 119 100 34 94
NAMENDA 110 110 35 117
NIASPAN 105 83 36 68
LOSARTAN POTASSIUM 101 66 37 26
CLONIDINE HCL 100 46 38 79
CITALOPRAM HBR 93 59 39 86
KLOR-CON 10 93 84 39 81
COMBIVENT 93 53 39 119
ZOLPIDEM TARTRATE 90 73 42 56
ATENOLOL 90 85 42 34
FAMOTIDINE 89 39 44 104
AZITHROMYCIN 88 57 45 88
BENICAR HCT 86 71 46 122
NOVOLOG FLEXPEN 83 29 47 14
KLOR-CON M20 77 44 48 98
NAPROXEN 74 30 49 128
DONEPEZIL HCL 74 73 49 106
CIPROFLOXACIN HCL 74 50 49 110
ACETAMINOPHEN-CODEINE 73 56 S3 52 111
ESCITALOPRAM OXALATE 73 34 52 129
AZOR 69 65 54 136
DIGOXIN 67 37 55 138
HUMALOG MIX 75-25 66 56 56 43
LYRICA 65 46 57 103
TRAZODONE HCL 65 61 57 106
PREDNISONE 63 31 59 64
HYDROCHLOROTHIAZIDE 62 26 60 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 39 61 51
TAMSULOSIN HCL 60 57 62 55
OXYBUTYNIN CHLORIDE ER 60 19 62 115
DIOVAN 59 39 64 32
FENOFIBRATE 58 38 65 50
SERTRALINE HCL 57 48 66 85
CALCITRIOL 57 45 66 74
ZETIA 56 27 68 58
PHENYTOIN SODIUM EXTENDED 56 19 68 105
RANITIDINE HCL 55 16 70 82
SPIRIVA 55 18 70 113
AMOX TR-POTASSIUM CLAVULANATE 55 37 70 145
IBANDRONATE SODIUM 55 45 70 145
MUPIROCIN 54 45 74 147
FINASTERIDE 53 53 75 150
POLYETHYLENE GLYCOL 3350 53 48 75 116
NITROSTAT 50 28 77 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.